The Danish National Diabetes Register (NDR) was established in 2006 and builds on data from Danish health registers. We validated the content of NDR, using full information from the Danish National Patient Register and data from the literature. Our study indicates that the completeness in NDR is $95% concerning ascertainment from data sources specific for diabetes, ie, prescriptions with antidiabetic drugs and diagnoses of diabetes in the National Patient Register. Since the NDR algorithm ignores diabetes-related hospital contacts terminated before 1990, the establishment of the date of inclusion is systematically delayed for $10% of the registrants in general and for $30% of the inclusions before 1997 in particular. This bias is enhanced for ascertainment by chiropody services and by frequent measurements of blood glucose because the date of reimbursement of services, rather than the date of encounter, has been taken as the date of inclusion in NDR. We also find that some 20% of the registrations in NDR may represent false positive inclusions of persons with frequent measurements of blood glucose without having diabetes. We conclude that NDR is a novel initiative to support research in the epidemiological and public health aspects of diabetes in Denmark, but we also present a list of recommended changes for improving validity, by reducing the impact of current sources of bias and misclassifications.
Introduction
Like the other Nordic countries, Denmark offers unique opportunities for register-based research in epidemiology and health care. 1, 2 Denmark has a particularly strong tradition of epidemiological research in diabetes, 3 which has been further enhanced with the establishment of the Danish National Diabetes Register (NDR) and the utilization of NDR for research purposes. 4, 5 We have previously used Danish health registers and population-based samples for studies of the epidemiological and public health aspects of diabetes. 6, 7 The establishment of NDR represents a new source for access to individual patient data that we are currently making use of, within the framework of a project called the Diabetes Impact Study 2013, to update our previous studies.
A study that used supplementary methods to ascertain persons with diabetes was performed recently in parts of the former county of Vejle and found that clinical characteristics and mortality differed according to the ascertainment methods applied. 8 We present here a comprehensive validation analysis of NDR, as part of the Diabetes Impact Study 2013.
the Danish National Prescription Registry, 10 and the Danish National Health Service Register 11 as well as the Danish Civil Registration System (DCRS). 12 In addition, NDR extracts information from DCRS on residence (municipality code) for each registrant as well as recorded survival status. Linkage of person-specific data between the registers is possible using the person identification number (PIN) that is assigned to each Danish citizen at birth or when granted Danish citizenship. For persons without Danish citizenship but with a permission to stay in Denmark, a temporary PIN is assigned. The PIN is unique and used for administrative purposes throughout the public and private sectors in Denmark, and is saved in the central health registers even after the death of the citizen. Table 1 provides an overview, based on the account of Carstensen et al, 4 of the main content of NDR, together with the data sources. The date that a given person is qualified for inclusion in NDR is known for each of the data sources (Table 1 ). The date of inclusion in NDR for a given person occurs when the first of any qualifying events (Table 1) for that person is fulfilled.
It should be noted that according to the detailed documentation, NDR ignores all hospital contacts terminated before 1990 in the search for diabetes-related activities in the DNPaR. 13 Overall, the algorithms employed are assumed to identify persons with diabetes with a high level of probability and to reduce false positive inclusion of young women with polycystic ovarian syndrome and women with gestational diabetes. NDR is supposed to include all persons with inclusion date since the start of 1997, as well as all persons who were alive at the end of 1996 and identified in the health registers with an inclusion date before 1997.
NDR is operated by the Statens Serum Institut and is updated on an annual basis, most recently by the inclusion of data for the year 2012. The content of NDR is available for research, provided permission is obtained from the Danish Data Protection Agency and the Danish National Board of Health.
supplementary data
The present analysis is based on the content of NDR, as extracted on July 3, 2013, containing the data on all inclusions in NDR until 2012. For all registered persons (n=497,232), data were extracted on all contacts (regardless of date) registered in DNPaR, containing information on all interventions performed, primary and secondary diagnoses underlying the contact, hospitalization, and all relevant dates. 9 The supplementary material presents a list of all diagnoses (according to International Classification of Disease [ICD]8 and ICD10 classifications) and intervention codes (according to the official Danish classification of codes in healthcare) used for this extraction. It should be noted that the codes for diabetes related to pregnancy (ICD10 code DO24) were not used for the purpose of obtaining supplementary data. In addition, all available data on moves, migrations, and deaths recorded on the population of NDR registrants were obtained from DCRS. 12 
Methods of analysis
All inclusions in NDR were described by ascertainment source. For this purpose, ascertainment by means of a diagnosis of diabetes in DNPaR was labeled "DMdiag". Ascertainment by frequency of blood glucose measurements ("blod2i5" and "blod5i1", respectively) was grouped to the ascertainment category "BSfreq" (Table 1) . Similarly, ascertainment by means of purchased antidiabetic drugs 
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Validation of the Danish national Diabetes register ("ins" and "oad") was grouped to the ascertainment category "AntiDiab". Ascertainment by receiving a service as a person with diabetes by a registered chiropodist was categorized as "Chiro".
Using the access to the full information from DNPaR, we identified for each registrant in NDR, all hospital contacts where diabetes formed part of the primary diagnosis or where interventions performed during the contact were specific for diabetes. The supplementary material contains the list of diagnostic codes (ICD8 classification for contacts before 1995; ICD10 classification for contacts for 2005 and forward) and the procedure codes specific for intervention in diabetes as used in all Danish hospitals. If such contacts were later than the inclusion date registered in NDR, the inclusion date in NDR was set operationally as the date of diagnosis of diabetes. If such contacts were earlier than the inclusion date registered in NDR, the earliest admission date was set operationally as the date of diagnosis.
Secondary ascertainment for a given patient occurred by the fulfillment of inclusion criteria by any other data sources than the first one. For each ascertainment, source methods for survival analysis 14 were used to estimate the cumulative probability of being ascertained by the first occurring secondary source. Patients were censored if death occurred before experiencing secondary ascertainment. All data were analyzed using anonymized PINs. Since this was a purely descriptive study without any prior specified hypotheses to be tested, only descriptive analyses were performed.
Ethical aspects
The Figure 2 . The annual number of inclusions, representing registration incidence, has increased steadily, from about 15,000 to more than 30,000, over the period 1997 through 2011. A relatively large increase has been seen for primary ascertainment by "AntiDiab", while the contribution from "DMdiag" has been rather constant and that for "BSfreq" has been modestly increasing. The number of inclusions by "Chiro" as the primary source is limited but shows relative increases during 2002-2004 and again for the year 2011.
secondary ascertainment in nDr
Inclusion in NDR may be qualified in several ways, and registrants may have been ascertained subsequently by other sources than by the primary ascertainment source with the earliest qualification fulfilled. Figure 3 shows the cumulative probability of ascertainment by at least one additional source, by follow-up time from the date of primary ascertainment. This analysis uses inclusions from 1997 throughout 2011. The patterns of cumulative probability vary by primary ascertainment source. For primary ascertainment by both "DMdiag" and "AntiDiab", some 80% of the persons will be ascertained by at least one additional source within a period of 10 years, however, with a sharper initial rise for persons primarily ascertained by "DMdiag". Primary ascertainment by "Chiro" is associated with a cumulative probability at a lower level and with a more slow increase. For persons primarily ascertained by "BSfreq", only about 50% will be ascertained by a second source and with only a modest initial sharp increase in the probability curve.
Operationally defined date of diagnosis of diabetes
Correspondence between the date of inclusion in NDR and the operationally defined date of diagnosis of diabetes, when using the full historical information in DNPaR, is shown in Table 2 , grouped by period of inclusion in NDR. Overall, the operational date of diagnosis equals the date of inclusion in NDR for almost 89% of persons. However, the percentage with agreement is only about 68% for persons with inclusion before 1997 against about 98% for persons with inclusion from 1997 and onward. The proportion of persons with more than 10 years of difference from operationally defined date of diagnosis until inclusion in NDR is about 10% for inclusion before 1997 against 0.4% for inclusion from 1997 and onward.
Discussion
NDR is a nationwide register that provides a unique platform for comprehensive research in the epidemiology and public health aspects of diabetes. As a main advantage, NDR makes 
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Validation of the Danish national Diabetes register use of already existing data that are routinely collected and maintained at the national level. As a further advantage, NDR attempts to cover both the secondary and the primary health care sector. In the attempt to validate important elements of NDR, the present study has identified several areas of concern about the validity of NDR, some of which may be alleviated by simple measures.
Validity of ascertainment in nDr
Ascertainment by purchase of antidiabetic drugs and by a primary hospital discharge diagnosis of diabetes as well as by diabetes-related chiropody may be characterized as specific for diabetes. However, the present list of diagnoses used for the identification of diabetes-related contacts in DNPaR is not complete and should be supplemented with diagnostic codes for diabetic eye complications. Furthermore, additional relevant contacts may be identified by codes of interventions specific for treatment of diabetes not included in the present NDR algorithm. Such codes may be identified by comparing the codes specified in Table 1 with the codes listed in the supplementary material. The use of such supplementary codes may not increase the ascertainment in NDR substantially but may optimize the establishment of date of inclusion in NDR. The inclusion of a substantial proportion of persons by means of the frequency of blood sugar measurements in the primary health care sector gives rise to concern about the validity of ascertainment, particularly because currently it is not possible to access information on the results of blood glucose measurements at the national level. Even though validation performed prior to the establishment of NDR indicated a high predictive value of diabetes for the "BSfreq" criteria currently used by NDR, 4 increased awareness in diabetes may have changed clinical practice and thereby changed Follow-up (years) from inclusion in NDR Cumulative probability (%) 
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green et al the predictive performance of the "BSfreq" algorithms. Our results show that the segment of registrants ascertained by "BSfreq" has a substantially lower probability, at about 50%, of being ascertained subsequently by a secondary source. This finding suggests that the group of persons ascertained exclusively by "BSfreq", to some extent, contains persons with blood sugar examined without having clinically diagnosed diabetes. According to a "worst-case" scenario, 50% of those 40% of registrants that are ascertained by "BSfreq" do not have diabetes; this corresponds to about 20% of the total population registered in NDR.
In a recent study, a regional algorithm based on information on glycosylated hemoglobin (HbA 1c ) measurements as a supplementary ascertainment source for the identification of persons with diabetes was compared with the algorithm used by NDR. 8 Based on an analysis of ascertainment patterns in about 14,000 persons ascertained jointly by the two algorithms, it was estimated that about 21% of persons ascertained by means of "BSfreq" in NDR may not have diagnosed diabetes but have their blood glucose examined frequently for other reasons. This estimate is close to the one presented above, which was obtained by a completely different approach. Furthermore, almost 700 persons were identified by the regional algorithm as having at least one elevated measurement of HbA 1c diagnostic of diabetes but without being registered with NDR. 8 Taking these findings as representing ascertainment failure in NDR, a proportionate analysis suggests the estimated completeness of diagnosed diabetes in NDR to be 93%-95%. Although a full systematic analysis of the completeness of ascertainment has been difficult because of differences in the definitions of the underlying patient populations, it is possible to perform formal analysis for specific segments. Thus, applying capture-recapture methods of analysis to the data in Table 1 Whereas the completeness of ascertained diagnosed diabetes in NDR may be 95% or higher, a substantial proportion, possibly amounting to about 20%, of the persons registered with NDR may have been falsely included by means of frequent measurement of blood glucose. In June 2012, the Danish National Board of Health decided to accept an HbA 1c level above 6.5% as a diagnostic criterion for diabetes. If readings of HbA 1c measurements will be accessible at the national level in the future, it should be considered to revise the algorithm for inclusion in NDR accordingly.
In terms of a full assessment of the performance of the algorithm of inclusion in NDR, the completeness of ascertainment is interpretable as the sensitivity, which we estimate to be 95% or higher. If further assumed that some 20% of the registrants in NDR do not have diabetes, the positive predictive value of ascertainment is about 80%. Applying a sensitivity at 95% and a positive predictive value at 80% in a scenario with a total population like the Danish, with some six million inhabitants and an annual number of new inclusions in NDR at 30,000, yields an estimated specificity (ie, the proportion of the total population without diabetes and that not ascertained by NDR) at 99.9%.
Date of inclusion in nDr versus operationally defined date of diagnosis of diabetes
Since the date of clinical diagnosis of diabetes cannot be recorded in NDR, it is necessary to use the date of inclusion as a proxy. This must be done with due reservation because in most cases, the clinical diagnosis may have been established before inclusion in NDR. 4 The impact of this form of bias may be reduced by searching for the earliest possible registration of diabetes-related contacts in the source registers, notably DNPaR. As per the current NDR algorithm, all hospital contacts closed before 1990 are ignored. 13 The reasons for this are not obvious, but the ignorance will enhance bias when using the date of inclusion in NDR as a proxy for the date of diagnosis of diabetes. Since our study takes account of all hospital activities, regardless of time, we can show that by ignoring contacts in DNPaR before 1990, more than 10% of the registrants have a delay in the operationally defined date of diagnosis. The delay affects more than 30% of the registrants with inclusion date before 1997 and is substantial, representing 10 years or even more for about 10% of the persons included in NDR before 1997. While this may not affect the completeness of ascertainment in NDR, it introduces a bias, particularly in investigations that involve the study of diabetes duration and the impact of diabetes duration over time.
Our study also has identified that persons may be included in NDR after death. To explore on this finding, we investigated further the timing of inclusion in NDR. It appears that for patients primarily ascertained by "DMdiag" and by "AntiDiab", the inclusion dates seem distributed by random, albeit with relatively fewer, inclusions during weekends. In contrast, primary ascertainment by "Chiro" is systematically associated with inclusion on Wednesdays, whereas primary ascertainment by "BSfreq" is associated 
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Validation of the Danish national Diabetes register with inclusion also on Wednesday, however with possible spacing between Wednesdays in intervals of up to 4 weeks or even more. Thus, it is likely that for inclusion by methods using contacts with health care providers in the primary health care sector, the inclusion date in NDR represents the date of reimbursement from the National Health Service to the health care provider, rather than the date of actual provision of service. Accordingly, a limited number of patients have died in the interval between the date of contact and the date of reimbursement. This element of the NDR algorithm enhances the bias when using date of inclusion in NDR as a proxy for date of diagnosis.
The present study has demonstrated how administrative changes may influence inclusion in NDR. The number of inclusions by "Chiro" as the primary source is limited but shows a distinct peak for the period 2002-2004 and again for the year 2011. These peaks coincide with periods during which agreements between the chiropodists and the National Health Service were in effect concerning reimbursement of expenses of chiropody for diabetic patients. In fact, the most recent summary report from NDR 15 shows a relative decrease in the number of new inclusions for the year 2012, which may be interpreted as a compensation for the relatively steep increase in 2011. Such fluctuations must be interpreted with appropriate caution to the extent that the inclusion rate in NDR is used as a proxy for the incidence rate of diabetes.
Conclusion and recommendations
NDR represents a novel initiative by which unique opportunities have been created for the monitoring of the basic epidemiological characteristics of diabetes as well as for further in-depth studies on the epidemiological and public health aspects of diabetes in Denmark. Comparisons with other samples of diabetic patients have suggested that NDR may perform with a high level of completeness of ascertainment. 8 Even though, our study has identified a range of issues that may question other aspects of the validity of NDR, with corresponding consequences for the use of NDR for research purposes. Some of these issues may be resolved by relatively simple changes in the NDR algorithm. Specifically, we recommend the following: 1) In the search for qualifying contacts in DNPaR, the NDR algorithm should include the content of the total DNPaR, rather than being limited to contacts after 1990. This simple measure will reduce substantially the bias in the operationally defined start of the diabetes course that preferentially exists for persons with inclusion date before 1997.
2) The set of diagnostic codes used in the NDR should be reviewed carefully and updated on a periodic basis with current and new relevant diagnostic codes and intervention codes specific for diabetes, as suggested in the supplementary material of this paper. While it may have limited impact only concerning the number of persons identified, such an improvement facilitates the establishment of a more qualified date of inclusion. 3) For inclusion by means of "BSfreq" and "Chiro", the true date of encounter, if available, in the Danish National Health Service Register should be used, rather than using the date of reimbursement. This will further support the establishment of a more qualified date of inclusion, and at the same time, the strikingly invalid feature of including persons after their death will be avoided. 4) As soon as results of HbA 1c measurements may become available as part of a future nationwide Danish laboratory database, the NDR algorithm should switch to rely upon the identification of measurements of elevated HbA 1c , instead of the frequency of blood glucose measurements. Such a switch will significantly reduce the false inclusion in NDR of persons with frequent blood glucose measurements for other clinical reasons than diabetes control. 5) Until the NDR algorithm has been further improved according to the recommendations presented here, we suggest performing sensitivity analyses with respect to the segment of persons ascertained by "BSfreq", in studies that make use of the content of NDR. 
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